title: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA.
authors.affiliation: Australian and New Zealand Combined Dialysis and Transplant Registry, Queen Elizabeth Hospital, Woodville, South Australia.
authors.forename: A G
authors.initials: AG
authors.lastname: Sheil
authors.forename: A P
authors.initials: AP
authors.lastname: Disney
authors.forename: T H
authors.initials: TH
authors.lastname: Mathew
authors.forename: N
authors.initials: N
authors.lastname: Amiss
authors.forename: L
authors.initials: L
authors.lastname: Excell
mesh_terms: D000367:Age Factors; D001379:Azathioprine / Q000009:adverse effects*; D002102:Cadaver; D003524:Cyclosporins / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000379:methods; D009369:Neoplasms / Q000209:etiology*; D012307:Risk Factors
chemical_list: D003524:Cyclosporins; D001379:Azathioprine